Of Nanochips and Persons: Toward an Ethics of Diagnostic Technology in Personalized Medicine

NanoEthics

Volumn 6, Issue 3, 2012, Pages 155-165

  Pellé, Sophie ^a   Nurock, Vanessa ^b  

^a UNIVERSITÉ PARIS 1 PANTHÉON SORBONNE   (France)

^b UNIVERSITÉ PARIS 8   (France)

Author keywords

Biochips; Capabilities; Care ethics; Nanotechnology; Personalized medicine

Indexed keywords

EID: 84870471384     PISSN: 18714757     EISSN: 18714765     Source Type: Journal    
DOI: 10.1007/s11569-012-0158-y     Document Type: Article

References (31)

1. Caruthers SD, Wickline SA, Lanza GM (2007) Nanotechnological applications in medicine. Curr Opin Biotechnol 18(1): 26-30.
2. Raffa V, Vittorio O, Riggio C, Cuschieri A (2010) Progress in nanotechnology for healthcare. Minim Invasive Ther 19(3): 127-135.
3. Jain KK (2007) Applications of nanobiotechnology in clinical diagnostics. Clin Chem 53(11): 2002-2009.
4. Chan P, Yuen T, Ruf F, Gonzalez-Moeso J & Sealfon SC (2005) Method for multiplexcellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucleic Acids Res 33 (18).
5. Villiers MB, Cortès S, Brakha C, Marche P, Roget A, Livache T (2009) Polypyrrole-peptide microarray for biomolecular interaction analysis by SPR imaging. Methods Mol Biol 570: 317-328.
6. Hill HD, Mirkin CA (2005) The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat Protoc 1: 324-336.
7. Nam JM, Wise AR, Groves JT (2005) Colorimetric bio-barcode amplification assay for cytokines. Anal Chem 77: 6985-6988.
8. Nazem A, Mansoori GA (2008) Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents. J Alzheimer's Dis 13(2): 199-233.
9. Goluch ED, Nam JM, Georganopoulou GD et al (2006) A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip 6: 1293-1299.
10. Bayertz K (1998) What's special about molecular genetic diagnostics. J Med Philos 23(3): 247-254.
11. Konrad M (2003) Predictive genetic testing and the making of the pre-symptomatic person: prognostic moralities amongst Huntington's-affected families. Anthropol Med 10(1): 24-47.
12. Jain KK (2002) Personalized medicine. Curr Opin Mol Ther 4(6): 548-558.
13. Netzer C, Biller-Androno N (2004) Pharmacogenetic testing, informed consent and the problem of secondary information. Bioethics 18(4): 344-360.
14. Schubert L (2004) Ethical implications of pharmacogenetics - Do slippery slope arguments matter? Bioethics 18(4): 361-378.
15. Smart A, Martin P, Parker M (2004) Tailored medicine: whom will it fit? The ethics of patient and disease stratification. Bioethics 18(4): 322-343.
16. Paul NW, Fangerau H (2006) Why should we bother? Ethical and social issues in individualized medicine. Curr Drug Targets 7(12): 1721-1727.
17. Marchant GE (2009) Small is beautiful: what Can nanotechnology do for personalized medicine? Curr Pharm Personalized Med 7(4): 231-237.
18. Bensaude-Vincent B, Larrère R, Nurock V (2008) "Pour une philosophie de terrain". In: Bensaude-Vincent B, Larrère R, Nurock V (eds) Bionano-ethique, perspectives critiques sur les bionanotechnologies. Vuibert, Paris, pp xi-xxx.
19. Bensaude-Vincent B & Nurock V (2010) « Nanoéthique», In: E. Hirsch, Traité de Bioéthique, Eres, 2010, T1 p. 355-369.
20. Dewey J (1939) Theory of valuation. (In O. Neurath, R. Carnap & C. W. Morris (Eds.), International Encyclopedia of Unified Science, 2(4), (pp 1-66). Chicago: University of Chicago Press).
21. Rawls J (1971) Theory of justice. Harvard University Press, Boston.
22. Kubik T, Bogunia-Kubik K, Sugisaka M (2005) Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 6: 17-33.
23. Weber M (2004) The Vocation Lectures: Science As a Vocation, Politics As a Vocation. Hackett Publishing Co.
24. Canguilhem G (1966 (1991)) The Normal and the Pathological. New York: Zone (tr: Fawcett CR: Le normal et le pathologique. Paris: Presses Universitaires de France).
25. Berquin A (2009) Les soins de santé, entre standardisation et personnalisation. Editions Seli Arslan, Paris.
26. Sen AK (1985) Well-being, agency and freedom: the Dewey lectures 1984. J Philos 82(4): 169-221.
27. Sen AK (2004) Incompleteness and reasoned choice. Synthese 140(1-2): 43-49.
28. Sen AK (2009) The idea of justice. Pinguin Books, London.
29. Issa AM (2002) Ethical perspectives on pharmacogenomics profiling in the drug development process. Nat Rev Drug Discov 1(4): 300-308.
30. Beauchamp TL, Childress JF (1989) Principles of biomedical ethics. University Press, Oxford.
31. Mol A (2008) The logic of care: health and the problem of patient choice. Routledge, New York.